Abstract
To study the effects of hypertension and other cardiovascular risk factors on risk of fractures, we carried out a case-control study including 124,655 fracture cases and 373,962 age- and gender-matched controls. The main exposure was hypertension, stroke, acute myocardial infarction, ischemic heart disease, atrial fibrillation, peripheral arterial disease, and deep venous thromboembolism, and the main confounders were use of diuretics, antihypertensive drugs, organic nitrates, vitamin K antagonists, and cholesterol lowering drugs along with other confounders. Hypertension and stroke were the only significant risk factors in both the short-term (OR = 1.27, 95% CI = 1.20–1.34 and 1.24, and 95% CI = 1.16–1.31 for ≤3 years since diagnosis of hypertension and stroke, respectively) and the long-term (OR = 1.11, 95% CI = 1.00–1.23 and 1.09, and 95% CI = 1.02–1.18 for > 6 years since diagnosis of hypertension and stroke, respectively) perspective. Acute myocardial infarction, atrial fibrillation, and deep venous thromboembolism were all associated with a transient increase in the risk of fractures within the first 3 years following diagnosis. Peripheral arterial disease and ischemic heart disease were not associated with an increased risk of fractures. In conclusion, hypertension and stroke seem to be the major cardiovascular risk factors for fractures, whereas acute myocardial infarction, atrial fibrillation, and deep venous thromboembolism seem to be only minor risk factors. The fracture risk in hypertension may explain why antihypertensive drugs as a class effect are associated with a decreased risk of fractures. These drugs may counter some of the deleterious effects of high blood pressure.
Similar content being viewed by others
References
Rejnmark L, Vestergaard P, Mosekilde L (2006) Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study. J Hypertension 24:581–589
Tanko LB, Bagger YZ, Christiansen C (2003) Low bone mineral density in the hip as a marker of advanced atherosclerosis in elderly women. Calcif Tissue Int 73:15–20
Cappuccio F, Meilahn E, Zmuda J et al (1999) High blood pressure and bone-mineral loss in elderly white women:a prospective study. Study of Osteoporotic Fractures Research Group. Lancet 354:971–975
McCarron D, Pingree P, Rubin R et al (1980) Enhanced parathyroid function in essential hypertension: a homeostatic response to a urinary calcium leak. Hypertension 2:162–168
Rejnmark L, Vestergaard P, Heickendorff L et al (2001) Effects of thiazide- and loop-diuretics, alone or in combination, on calciotropic hormones and biochemical bone markers: a randomized controlled study. J Intern Med 250:144–150
Rejnmark L, Vestergaard P, Mosekilde L (2005) Reduced fracture risk in users of thiazide diuretics. Calcif Tissue Int 76:167–175
Marcovitz PA, Tran HH, Franklin BA et al (2005) Usefulness of bone mineral density to predict significant coronary artery disease. Am J Cardiol 96:1059–1063
Rejnmark L, Vestergaard P, Mosekilde L (2006) Decreased fracture risk in users of organic nitrates:a nationwide case-control study. J Bone Miner Res 21:1811–1817
Bauer D (2003) HMG CoA reductase inhibitors and the skeleton: a comprehensive review. Osteoporosis Int 14:273–282
Meier C, Schlienger R, Kraenzlin M et al (2000) HMG-CoA reductase inhibitors and the risk of fracture. JAMA 283:3205–3210
Wang P, Solomon D, Mogun H et al (2000) HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA 283:3211–3216
Luckman S, Hughes D, Coxon F et al (1998) Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. J Bone Miner Res 13:581–589
Rejnmark L, Vestergaard P, Mosekilde L (2006) Statin but not non-statin lipid-lowering drugs decrease fracture risk:a nation-wide case-control study. Calcif Tissue Int 79:27–36
Rejnmark L, Vestergaard P, Mosekilde L (2006) Fracture risk in patients treated with amiodarone or digoxin for cardiac arrhythmias: a nation-wide case-control study. Osteoporos Int 18:409–417
Vestergaard P, Emborg C, Støving R et al (2002) Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders—a nation-wide register study. Int J Eat Disord 32:301–308
Andersen T, Madsen M, Jørgensen J et al (1999) The Danish National Hospital Register. Danish Med Bull 46:263–268
Mosbech J, Jørgensen J, Madsen M et al (1995) The Danish National Patient Register: evaluation of data quality. Ugeskr Laeger 157:3741–3745
Vestergaard P, Rejnmark L, Mosekilde L (2004) Fracture risk associated with use of anti-epileptic drugs. Epilepsia 45:1330–1337
Vestergaard P, Rejnmark L, Mosekilde L (2006) Socioeconomic aspects of fractures within universal public healthcare: a nationwide case-control study from Denmark. Scand J Public Health 34:371–377
Kanis J, Johansson H, Johnell O et al (2005) Alcohol intake as a risk factor for fracture. Osteoporosis Int 16:737–742
Klotzbuecher C, Ross P, Landsman P et al (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the litterature and statistical synthesis. J Bone Miner Res 15:721–739
Munk-Jørgensen P, Mortensen P (1997) The Danish Psychiatric Central Register. Danish Med Bull 44:82–84
Vestergaard P, Mosekilde L (2002) Fracture risk in patients with celiac disease, Crohn’s disease, and ulcerative colitis: a nation-wide follow-up study in 16, 416 patients in Denmark. Am J Epidemiol 156:1–10
Krarup L, Boysen G, Janjua H et al (2007) Validity of stroke diagnoses in a National Register of Patients. Neuroepidemiology 28:150–154
Madsen M, Balling H, Eriksen L (1990) The validity of the diagnosis of acute myocardial infarction in 2 registries: the Heart Registry compared to the National Patient Registry. Ugeskr Laeger 152:308–314
Nielsen HW, Tüchsen F, Jensen MV (1996) Validity of the diagnosis “essential hypertension” in the National Patient Registry. Ugeskr Laeger 158:163–167
Cirillo M, Galletti F, Corrado M et al (1986) Disturbances of renal and erythrocyte calcium handling in rats of the Milan hypertensive strain. J Hypertens 4:443–449
Cirillo M, Galletti F, Strazzullo P et al (1989) On the pathogenetic mechanism of hypercalciuria in genetically hypertensive rats of the Milan strain. Am J Hypertens 2:741–746
Cirillo M, Strazzullo P, Galletti F et al (1985) The effect of an intravenous calcium load on serum total and ionized calcium in normotensive and hypertensive subjects. J Clin Hypertens 1:30–34
Strazzullo P, Cappuccio F, De Leo A et al (1987) Calcium metabolism and blood pressure in children. J Hum Hypertens 1:155–159
Strazzullo P, Galletti F, Cirillo M et al (1986) Altered extracellular calcium homoeostasis in essential hypertension: a consequence of abnormal cell calcium handling. Clin Sci (Lond) 71:239–244
Strazzullo P, Galletti F, Siani A et al (1984) Altered kinetics of an intravenous calcium load in hypertensive patients. J Hypertens 2(3, Suppl 2): S499–S501
Strazzullo P, Nunziata V, Cirillo M et al (1983) Abnormalities of calcium metabolism in essential hypertension. Clin Sci 65:137–141
Strazzullo P, Siani A, Gugliemi S et al (1986) Controlled trial of long-term oral calcium supplementation in essential hypertension. Hypertension 8:1084–1088
Rejnmark L, Vestergaard P, Mosekilde L (2006) Fracture risk in patients treated with loop diuretics. J Inter Med 259:117–124
Keenan M, Perry J, Jordan C (1984) Factors affecting balance and ambulation following stroke. Clin Orthop Rel Res 182:165–171
Melton L III, Brown R Jr, Achenbach S et al (2001) Long-term fracture risk following ischemic stroke: a population-based study. Osteoporosis Int 19:980–986
Poplinger A, Pillar T (1985) Hip fracture in stroke patients: epidemiology and rehabilitation. Acta Orthop Scand 56:226–227
Ramnemark A, Nyberg L, Borss B et al (1998) Fractures after stroke. Osteoporosis Int 8:92–95
Browner W, Pressman A, Nevitt M et al (1993) Association between low bone density and stroke in elderly women. The study of osteoporotic fractures. Stroke 24:940–946
Hamdy R, Krishnaswamy G, Cancellaro V et al (1993) Changes in bone mineral content and density after stroke. Am J Phys Med Rehab 72:188–191
Hamdy R, Moore S, Cancellaro V et al (1995) Long-term effects of strokes on bone mass. Am J Phys Med Rehab 74:351–356
Jorgensen L, Jacobsen B, Wilsgaard T et al (2000) Walking after stroke: Does it matter? Changes in bone mineral density within the first 12 months after stroke. A longitudinal study. Osteoporosis Int 11:381–387
Liu M, Tsuji T, Higuchi Y et al (1999) Osteoporosis in hemiplegic stroke patients as studied with dual-energy X-ray absorptiometry. Arch Phys Med Rehab 80:1219–1226
Ramnemark A, Nyberg L, Lorentzon R et al (1999) Progressive hemiosteoporosis on the paretic side and increased bone mineral density in the nonparetic arm the first year after severe stroke. Osteoporosis Int 9:269–275
Sahin L, Zoran K et al (2001) Bone mineral density in patients with stroke. Am J Phys Med Rehab 80:592–596
Sato Y, Fujimatsu Y, Kikuyama M et al (1998) Influence of immobilization on bone mass and bone metabolism in hemiplegic elderly patients with a long-standing stroke [comment]. J Neurol Sci 156:205–210
Christiansen C, Christensen M, McNair P et al (1980) Prevention of early bone postmenopausal loss: controlled 2-year study in 315 normal females. Eur J Clin Invest 10:273–279
Greendale G, Lee N, Arriola E (1999) The menopause. Lancet 353:571–580
Vestergaard P, Hermann A, Stilgren L et al (2003) Effects of 5 years of hormonal replacement therapy on menopausal symptoms and blood pressure: a randomised controlled study. Maturitas 46:123–132
Jenkins D, Cochran T (1969) Osteoporosis: the dramatic effect of disuse of an extremity. Clin Orthop 64:128–134
Abramson A, Delagi E (1961) Influence of weight-bearing and muscle contraction on disuse osteoporosis. Arch Phys Med Rehab 42:147–151
Vestergaard P, Rejnmark L, Mosekilde L (2005) Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia 48:1292–1299
Acknowledgments
The Danish Medical Research Council granted financial support for this study (Grant 22–04-0495). Danmarks Statistik (Statistics Denmark) is acknowledged for their help, without which this project would not have been possible. Research Librarian Ms. Edith Clausen is acknowledged for invaluable help with the references.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vestergaard, P., Rejnmark, L. & Mosekilde, L. Hypertension Is a Risk Factor for Fractures. Calcif Tissue Int 84, 103–111 (2009). https://doi.org/10.1007/s00223-008-9198-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-008-9198-2